Annual CFI
$91.79 M
+$95.32 M+2702.40%
September 30, 2024
Summary
- As of February 26, 2025, EPIX annual cash flow from investing activities is $91.79 million, with the most recent change of +$95.32 million (+2702.40%) on September 30, 2024.
- During the last 3 years, EPIX annual CFI has risen by +$126.80 million (+362.14%).
- EPIX annual CFI is now at all-time high.
Performance
EPIX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$3.93 M
-$24.95 M-118.69%
December 31, 2024
Summary
- As of February 26, 2025, EPIX quarterly cash flow from investing activities is -$3.93 million, with the most recent change of -$24.95 million (-118.69%) on December 31, 2024.
- Over the past year, EPIX quarterly CFI has dropped by -$24.95 million (-118.69%).
- EPIX quarterly CFI is now -106.28% below its all-time high of $62.51 million, reached on March 31, 2024.
Performance
EPIX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$79.63 M
-$12.16 M-13.25%
December 31, 2024
Summary
- As of February 26, 2025, EPIX TTM cash flow from investing activities is $79.63 million, with the most recent change of -$12.16 million (-13.25%) on December 31, 2024.
- Over the past year, EPIX TTM CFI has dropped by -$12.16 million (-13.25%).
- EPIX TTM CFI is now -13.25% below its all-time high of $91.79 million, reached on September 30, 2024.
Performance
EPIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EPIX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2702.4% | -118.7% | -13.3% |
| 3 y3 years | +362.1% | -118.7% | -13.3% |
| 5 y5 years | +10000.0% | -118.7% | -13.3% |
EPIX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +273.0% | -106.3% | +85.3% | -13.3% | +250.1% |
| 5 y | 5-year | at high | +273.0% | -106.3% | +88.8% | -13.3% | +240.3% |
| alltime | all time | at high | +273.0% | -106.3% | +88.8% | -13.3% | +240.3% |
ESSA Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$3.93 M(-118.7%) | $79.63 M(-13.2%) |
| Sep 2024 | $91.79 M(-2702.4%) | $21.02 M(>+9900.0%) | $91.79 M(+30.2%) |
| Jun 2024 | - | $23.50 K(-100.0%) | $70.50 M(+1.3%) |
| Mar 2024 | - | $62.51 M(+659.3%) | $69.59 M(+1022.4%) |
| Dec 2023 | - | $8.23 M(-3211.3%) | $6.20 M(-275.8%) |
| Sep 2023 | -$3.53 M(-93.4%) | -$264.60 K(-70.3%) | -$3.53 M(-46.6%) |
| Jun 2023 | - | -$891.10 K(+1.6%) | -$6.61 M(-62.9%) |
| Mar 2023 | - | -$877.20 K(-41.3%) | -$17.80 M(-59.1%) |
| Dec 2022 | - | -$1.49 M(-55.4%) | -$43.55 M(-17.9%) |
| Sep 2022 | -$53.05 M(+51.5%) | -$3.35 M(-72.3%) | -$53.05 M(+6.7%) |
| Jun 2022 | - | -$12.08 M(-54.6%) | -$49.71 M(+32.1%) |
| Mar 2022 | - | -$26.63 M(+142.1%) | -$37.64 M(-18.2%) |
| Dec 2021 | - | -$11.00 M(<-9900.0%) | -$46.01 M(+31.4%) |
| Sep 2021 | -$35.01 M(+61.1%) | $0.00(-100.0%) | -$35.01 M(-38.3%) |
| Jun 2021 | - | -$11.30 K(-100.0%) | -$56.75 M(+0.0%) |
| Mar 2021 | - | -$35.00 M(<-9900.0%) | -$56.74 M(+161.0%) |
| Dec 2020 | - | $0.00(-100.0%) | -$21.74 M(0.0%) |
| Sep 2020 | -$21.74 M | -$21.74 M(<-9900.0%) | -$21.74 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2020 | - | $0.00(0.0%) | $201.40 K(0.0%) |
| Sep 2019 | $201.40 K(-200.0%) | $0.00(-100.0%) | $201.40 K(>+9900.0%) |
| Jun 2019 | - | $201.40 K(-200.0%) | $0.00(-100.0%) |
| Sep 2018 | -$201.40 K(<-9900.0%) | -$201.40 K(<-9900.0%) | -$201.40 K(<-9900.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2017 | $0.00(-100.0%) | - | - |
| Sep 2016 | -$10.00 K(-94.3%) | $0.00(0.0%) | -$10.00 K(-85.7%) |
| Jun 2016 | - | $0.00(-100.0%) | -$69.80 K(-41.3%) |
| Mar 2016 | - | -$8000.00(+300.0%) | -$118.90 K(-1.4%) |
| Dec 2015 | - | -$2000.00(-96.7%) | -$120.60 K(-30.7%) |
| Sep 2015 | -$174.10 K(<-9900.0%) | -$59.80 K(+21.8%) | -$174.10 K(+52.3%) |
| Jun 2015 | - | -$49.10 K(+406.2%) | -$114.30 K(+75.3%) |
| Mar 2015 | - | -$9700.00(-82.5%) | -$65.20 K(+17.5%) |
| Dec 2014 | - | -$55.50 K(<-9900.0%) | -$55.50 K(<-9900.0%) |
| Sep 2014 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00 | $0.00 |
FAQ
- What is ESSA Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for ESSA Pharma?
- What is ESSA Pharma annual CFI year-on-year change?
- What is ESSA Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ESSA Pharma?
- What is ESSA Pharma quarterly CFI year-on-year change?
- What is ESSA Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for ESSA Pharma?
- What is ESSA Pharma TTM CFI year-on-year change?
What is ESSA Pharma annual cash flow from investing activities?
The current annual CFI of EPIX is $91.79 M
What is the all time high annual CFI for ESSA Pharma?
ESSA Pharma all-time high annual cash flow from investing activities is $91.79 M
What is ESSA Pharma annual CFI year-on-year change?
Over the past year, EPIX annual cash flow from investing activities has changed by +$95.32 M (+2702.40%)
What is ESSA Pharma quarterly cash flow from investing activities?
The current quarterly CFI of EPIX is -$3.93 M
What is the all time high quarterly CFI for ESSA Pharma?
ESSA Pharma all-time high quarterly cash flow from investing activities is $62.51 M
What is ESSA Pharma quarterly CFI year-on-year change?
Over the past year, EPIX quarterly cash flow from investing activities has changed by -$24.95 M (-118.69%)
What is ESSA Pharma TTM cash flow from investing activities?
The current TTM CFI of EPIX is $79.63 M
What is the all time high TTM CFI for ESSA Pharma?
ESSA Pharma all-time high TTM cash flow from investing activities is $91.79 M
What is ESSA Pharma TTM CFI year-on-year change?
Over the past year, EPIX TTM cash flow from investing activities has changed by -$12.16 M (-13.25%)